Literature DB >> 1669511

Obesity, blood pressure, and the sympathetic nervous system.

L Landsberg1, R Troisi, D Parker, J B Young, S T Weiss.   

Abstract

Obesity has long been recognized as a major risk factor for the development of hypertension. Recently, insulin level has been shown to correlate with blood pressure in clinical and population-based studies. Since insulin is a major signal in the relationship between dietary intake and sympathetic nervous system activity, the possibility that insulin-mediated sympathetic stimulation is involved in the pathogenesis of hypertension in the obese has been raised. This hypothesis, developed on the basis of studies in laboratory rodents and normal human subjects, is currently being tested in the Normative Aging Study in Boston. Utilizing epidemiologic techniques applied to this defined population, evidence in support of this hypothesis has been accumulated. The preliminary results indicate that in this population, the abdominal form of obesity is associated with higher insulin levels and increased 24-hour urinary norepinephrine excretion (an index of sympathetic activity).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1669511     DOI: 10.1016/1047-2797(91)90040-j

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  9 in total

Review 1.  Stress and salt sensitivity in primary hypertension.

Authors:  Deborah L Stewart; Gregory A Harshfield; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

Review 3.  Social factors and cardiovascular morbidity.

Authors:  Eric John Brunner
Journal:  Neurosci Biobehav Rev       Date:  2016-05-10       Impact factor: 8.989

4.  Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.

Authors:  Leandro Boer-Martins; Valéria N Figueiredo; Caroline Demacq; Luiz C Martins; Fernanda Consolin-Colombo; Márcio J Figueiredo; Fernando P S Cannavan; Heitor Moreno
Journal:  Cardiovasc Diabetol       Date:  2011-03-22       Impact factor: 9.951

5.  Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome.

Authors:  Celestino Sardu; Matteo Santamaria; Stefania Funaro; Cosimo Sacra; Michelangela Barbieri; Pasquale Paolisso; Raffaele Marfella; Giuseppe Paolisso; Maria Rosaria Rizzo
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Moderating Effect of BMI on the Relationship Between Sympathetic Activation and Blood Pressure in Males with Obstructive Sleep Apnea.

Authors:  Baixin Chen; Virend K Somers; Xiangdong Tang; Yun Li
Journal:  Nat Sci Sleep       Date:  2021-03-11

7.  Cardiovascular Risk Reduction Associated with Pharmacological Weight Loss: A Meta-Analysis.

Authors:  Jesse A Kane; Talha Mehmood; Irsa Munir; Haroon Kamran; Pramod Theetha Kariyanna; Angelina Zhyvotovska; Denis Yusupov; Umer Javed Suleman; Deborah R Gustafson; Samy I McFarlane
Journal:  Int J Clin Res Trials       Date:  2019-01-21

Review 8.  Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System.

Authors:  Benedetta Russo; Marika Menduni; Patrizia Borboni; Fabiana Picconi; Simona Frontoni
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 9.  Overweight, physical activity and high blood pressure in children: a review of the literature.

Authors:  Brian Torrance; K Ashlee McGuire; Richard Lewanczuk; Jonathan McGavock
Journal:  Vasc Health Risk Manag       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.